GeraClinic / NHS cancer waiting times / NHS Gloucestershire ICB
NHS Gloucestershire ICB: NHS Cancer Waiting Times
In April 2026, 77.6% of cancer patients in NHS Gloucestershire ICB started treatment within 62 days of urgent referral — 7.8 percentage points above the England average. Gera Cancer Pathway Pressure Index: 0/100 (lowest pathway pressure). Official NHS England data.
What is the NHS cancer waiting time in NHS Gloucestershire ICB?
As of April 2026, 77.6% of cancer patients in NHS Gloucestershire ICB started treatment within 62 days of urgent referral — 7.8 percentage points above the England average (NHS target: 85%) — covering 295 patients, per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
The GCPPI for NHS Gloucestershire ICB = (1 − 77.6% / 100) × 2,471 FDS referrals = raw pressure 554, normalised to 0/100. Rank 36 of 36 ICBs (rank 1 = most pressure). See methodology.
| Measure | NHS Gloucestershire ICB | What it means |
|---|---|---|
| 62-day standard met | 77.6% | NHS target: 85% |
| 28-day FDS met | 73.9% | NHS target: 75% |
| Patients in 62-day pathway | 295 | All four 62-day sub-pathways |
| FDS referral volume | 2,471 | Faster Diagnosis Standard demand |
| Gera Pressure Index (GCPPI) | 0 / 100 | lowest pathway pressure |
| Pathway pressure rank | 36 / 36 | Rank 1 = most pressure in England |
| Pathway | Patients | 62-day met | Standard |
|---|---|---|---|
| Urgent Suspected Cancer | 170 | 74.7% | Missed |
| Screening | 28 | 67.9% | Missed |
| Consultant Upgrade | 96 | 85.4% | Met |
| Breast Symptomatic | 1 | 100.0% | Met |
Check your area's cancer pathway pressure
Compare NHS Gloucestershire ICB with other ICBs — real NHS data, updated monthly
In NHS Gloucestershire ICB, 77.6% of cancer patients started treatment within 62 days of urgent referral in April 2026 — 7.8 percentage points above the England average. The NHS standard is 85%.
62-day standard met
77.6%
NHS target: 85%
28-day FDS met
73.9%
Faster Diagnosis Standard (75%)
Gera Pressure Index
0 / 100
lowest pathway pressure
295 patients reached a 62-day treatment decision in this ICB (April 2026); England total: 27,522.
Pathway breakdown (62-day, April 2026):
| Pathway | Patients | Met standard |
|---|---|---|
| Urgent Suspected Cancer | 170 | 74.7% |
| Screening | 28 | 67.9% |
| Consultant Upgrade | 96 | 85.4% |
| Breast Symptomatic | 1 | 100.0% |
NHS Gloucestershire ICB is at 77.6% on the 62-day standard — below the NHS 85% target. GeraClinic can connect you to a cancer specialist quickly while you await NHS assessment.
Book a cancer consultationCompare cancer waiting times in other areas
Sorted by Gera Cancer Pathway Pressure Index (highest pressure first).
- NHS Surrey And Sussex ICB (GCPPI 100)
- NHS Essex ICB (GCPPI 93.4)
- NHS North East And North Cumbria ICB (GCPPI 75.5)
- NHS West And North London ICB (GCPPI 68.7)
- NHS Central East ICB (GCPPI 68.3)
- NHS Lancashire And South Cumbria ICB (GCPPI 63.6)
- NHS Greater Manchester ICB (GCPPI 62.9)
- NHS Cheshire And Merseyside ICB (GCPPI 61.2)
- NHS Norfolk And Suffolk ICB (GCPPI 55.5)
- NHS Thames Valley ICB (GCPPI 55.3)
- NHS South East London ICB (GCPPI 50.5)
- NHS West Yorkshire ICB (GCPPI 48.8)
- All 36 ICBs & the England average →
NHS Gloucestershire ICB cancer waiting times: FAQs
- What is the NHS cancer 62-day waiting time in NHS Gloucestershire ICB?
- In April 2026, 77.6% of cancer patients in NHS Gloucestershire ICB started treatment within 62 days of urgent referral — 7.8 percentage points above the England average. The NHS target is 85%. Data: NHS England Cancer Waiting Times.
- What is the Gera Cancer Pathway Pressure Index for NHS Gloucestershire ICB?
- The Gera Cancer Pathway Pressure Index (GCPPI) for NHS Gloucestershire ICB in April 2026 is 0/100 (lowest pathway pressure). It is computed as (1 − 62-day standard met rate) × referral volume, normalised across all 36 ICBs. NHS Gloucestershire ICB ranks 36 of 36 ICBs by pathway pressure.
- How does NHS Gloucestershire ICB compare on the 28-day Faster Diagnosis Standard?
- In April 2026, 73.9% of patients in NHS Gloucestershire ICB received a cancer diagnosis or ruling-out within 28 days (NHS FDS target: 75%). NHS Gloucestershire ICB processed 2,471 FDS referrals in this period, per NHS England Cancer Waiting Times data.
- Can I be seen privately while waiting for cancer assessment in NHS Gloucestershire ICB?
- Yes. Being assessed or treated privately does not affect your NHS referral. GeraClinic can connect you to a UK-registered cancer specialist. You keep your place on the NHS list and can access a private consultation simultaneously.
- What are the main cancer pathways in NHS Gloucestershire ICB?
- The NHS 62-day standard in NHS Gloucestershire ICB covers four pathways: Urgent Suspected Cancer (the primary 2-week-wait route), Screening (referrals from NHS screening programmes), Consultant Upgrade (reclassification onto the 62-day pathway by a clinician), and Breast Symptomatic (non-2WW breast referrals). In April 2026, NHS Gloucestershire ICB recorded 295 patients across all four pathways.
NHS Gloucestershire ICB is below the NHS 85% cancer target
Only 77.6% of cancer patients in NHS Gloucestershire ICB met the 62-day standard in April 2026 (NHS target: 85%). GeraClinic can connect you to a UK-registered cancer specialist quickly — you keep your NHS referral while getting faster private assessment.
Data and methodology
Figures for NHS Gloucestershire ICB are aggregated from the real per-sub-location count rows in NHS England's April 2026 Cancer Waiting Times ICB Sub-Location extract. Each sub-location code (e.g. multiple [ICB sub-location codes, NHS ODS]) is mapped to its parent ICB via the NHS Organisation Data Service and summed for both the 62-day Combined and 28-day FDS standards. Percentages are re-derived from summed numerators and denominators — not averaged. The Gera Cancer Pathway Pressure Index = (1 − 62-day met rate) × referral volume, normalised 0–100. No estimates or invented numbers. See full methodology.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0.